TORONTO, July 24, 2014 /CNW/ - Biosign
Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") is
pleased to announce the appointment of Ron Kelusky to the Board. Mr. Kelusky is the
President & CEO of Public Services Health & Safety
Association of Ontario
(PSHSA). PSHSA works with Ontario's 10,000 public and broader public
service sector employers and 1.5 million workers, offering
consulting, training, resources, plus health & safety products
and information to clients in health and community care, education
and culture, municipal and provincial government, and public safety
and First Nations communities. From 2009-2013 Mr Kelusky was
Director General of the Canadian Red Cross, responsible for
Ontario operations and all
National Health programming, overseeing 4,000 full and part time
staff, 6,000 volunteers and an annual operating budget of
$175.0 million. From 2006 - 2009 he
was President, Health Division for GestureTek Incorporated; from
2003-2006 he was Chief Operating Officer for March of Dimes Canada;
and from 1998-2003 he served as Chief and General Manager for the
City of Toronto Emergency Medical
Services. Mr. Kelusky has an MBA from Athabasca University.
With this change, the Board now consists of Dr. Michael Gross (Chairman), Mr. Dennis Rygwalski (Chair of the Audit Committee),
Mr. Ron Kelusky, Mr. Brian Neill and Mr. Robert Kaul (Biosign CEO).
Mr. Kaul stated: "We are fortunate to be able to welcome Mr.
Kelusky to our team. As a very experienced manager, executive &
public servant, he brings to us a strong body of knowledge in
pertinent fields of health, wellness, homecare and aging-in-place.
His advice and counsel will be instrumental to our future as a
leading provider of healthcare solutions. The appointment of Mr.
Kelusky is a further indication that our restructuring plan is
nearing completion, and a strong endorsement of the leadership and
direction of the management team."
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides automated,
software enabled health information solutions including the
Pulsewave™ Health Monitor and the Healthanywhere™ Patient
monitoring / self-care platform. The Company's various software
solutions, including Clinicserver™ and PencilThat™ offer
industry-leading allied health clinic and patient centered care
management. The Company also offers a number of cardiovascular
screening programs for consumers under its Heart Friendly™ brand,
including Heart Friendly™ Practice, Heart Friendly™ Dentist, and
Heart Friendly™ Fitness. For more information on Biosign, please
visit www.biosign.com
Forward-Looking Statements
This release contains forward-looking statements.
Forward-looking statements, without limitation, may contain the
words believes, expects, anticipates, estimates, intends, plans, or
similar expressions. Forward-looking statements are not guarantees
of future performance. They involve risks, uncertainties and
assumptions and Biosign's actual results could differ materially
from those anticipated. Forward looking statements are based on the
opinions and estimates of management at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
In the context of any forward-looking information please refer to
risk factors detailed in, as well as other information contained in
the company's filings with Canadian securities regulators
(www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE Biosign Technologies Inc.